| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |